Glaucoma Insights

BU researcher receives BrightFocus award

September 12, 2022

Haiyan Gong, MD, PhD, professor of ophthalmology and anatomy and neurobiology at Boston University School of Medicine, has received $200,000 through a Standard Award in National Glaucoma Research from the BrightFocus Foundation.

Study focuses on technology to unveil optical texture and trajectories of the axonal fiber bundles on retina

September 12, 2022

A research team led by the Department of Ophthalmology, School of Clinical Medicine, LKS Faculty of Medicine of The University of Hong Kong, with collaborators from the Faculty of Medicine of The Chinese University of Hong Kong and local and international partners, have developed a new technology ROTA to unveil the optical texture and trajectories of the axonal fiber bundles on the retina.

Iantrek raises $23 million in Series B financing for development of MIGS devices in US

August 31, 2022

The first cases in the United States using the company’s suprachoroidal technology were performed earlier this month, and long-term clinical outcomes will be presented at the annual meeting of the American Academy of Ophthalmology in Chicago, starting Sept. 30.

Investigators get to the root of ocular infections

August 29, 2022

The research points to the importance of isolating offending organism.

Sight Sciences releases long-term safety, efficacy data of standalone use of Omni surgical system in patients with open angle glaucoma

August 16, 2022

According to the company, a study shows the non-implantable minimally invasive glaucoma surgery effectively reduces IOP and reduces need for IOP-lowering medications in patients diagnosed with open-angle glaucoma.

High-tech imaging offers new way to detect early signs of glaucoma

August 04, 2022

According to a new study from New York Eye and Ear Infirmary of Mount Sinai, a new, non-invasive ocular imaging method may be able to detect an early indicator of glaucoma in time to prevent disease progression and vision loss.

Alternative delivery of glaucoma medications more than a dream

July 30, 2022

Bausch + Lomb, Sanoculis announce strategic agreements to address unmet needs in glaucoma

July 29, 2022

Bausch + Lomb has made an equity investment in Sanoculis and has entered into an exclusive European distribution agreement for MIMS minimally invasive surgical procedure.

Redesigned probe for micropulse transscleral laser therapy for glaucoma proves less is more

June 27, 2022

The lower energy applications and slower sweep speeds offer marked IOP reductions in patients.

Sight Sciences announces first patient treated in TRIDENT European trial

March 28, 2022

Novel trial design will compare safety and effectiveness outcomes for the OMNI Surgical System and the iStent inject in lowering IOP as a standalone treatment option without concomitant cataract surgery.